產(chǎn)品詳情
簡單介紹：
Anti-Cubilin抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-Cubilin抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-Cubilin
Cat. Number:
Anti-Cubilin抗體KL-3901R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Cubilin is an endocytic receptor that lacks a classical transmembrane region. It is a multidomain receptor that contains an amino terminal 110 residue segment followed by 8 epidermal growth factor (EGF)-like repeats and aAnti-Cubilin抗體 contiguous stretch of 27 CUB domains. Cubilin acts as a receptor for intrinsic factor-vitamin B12 complexes. Cubilin is located within the epithelium of intestine and kidney. Cubilin co-localizes with and binds to Megalin, a 600kDa member of the LDL receptor family that is required for the internalization of cubilin-bound ligands, such as vitamin B12, apolipoprotein A1 and Albumin. Megalin specifically binds to cubilin in the amino terminal region that contains the EGF-like repeats and CUB domains 1 and 2. Mutations in Cubilin may play a role in autosomal recessive megaloblastic anemia also known as Imerslund-Grasbeck’s disease, which causes intestinal malabsorption of vitamin B12.
Also known as:
460 kDa receptor; cubilin Anti-Cubilin抗體(intrinsic factor-cobalamin receptor); Cubilin precursor; CUBN; IFCR; Intestinal intrinsic factor receptor; intrinsic factor B12-receptor; intrinsic factor-cobalamin receptor; intrinsic factor-vitamin B12 receptor; megaloblastic anemia 1; MGA1.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthetic peptide derived from human Cubilin (48-90aa).
●
Predicted Molecular Weight: 395kDa.
Storage:
Shipped at 4℃, Store at -20℃Anti-Cubilin抗體 (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions Anti-Cubilin抗體must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions Anti-Cubilin抗體must be determined by the end user.
kl383Mu01 磷酸肌醇-3-激酶2α肽(PI3K2α)多克隆抗體 Polyclonal Antibody to Phosphoinositide-3-Kinase Class-2-Alpha Polypeptide (PIK3C2a)
kl384Hu01 白介素23(IL23)多克隆抗體 Polyclonal Antibody to Interleukin 23 (IL23)
kl384Mu01 白介素23(IL23)多克隆抗體 Polyclonal Antibody to Interleukin 23 (IL23)
kl384Ra01 白介素23(IL23)多克隆抗體 Polyclonal Antibody to Interleukin 23 (IL23)
kl385Hu01 白介素27(IL27)多克隆抗體 Polyclonal Antibody to Interleukin 27 (IL27)
kl385Ra01 白介素27(IL27)多克隆抗體 Polyclonal Antibody to Interleukin 27 (IL27)
kl389Mu01 補(bǔ)體成分4a(C4a)多克隆抗體 Polyclonal Antibody to Complement Component 4a (C4a)
kl389Ra01 補(bǔ)體成分4a(C4a)多克隆抗體 Polyclonal Antibody to Complement Component 4a (C4a)
kl391Hu01 卵泡抑素(FS)多克隆抗體 Polyclonal Antibody to Follistatin (FS)
kl391Mu01 卵泡抑素(FS)多克隆抗體 Polyclonal Antibody to Follistatin (FS)
kl392Hu01 速激肽受體1(TACR1)多克隆抗體 Polyclonal Antibody to Tachykinin Receptor 1 (TACR1)
kl394Hu01 組織因子通道抑制因子(TFPI)多克隆抗體 Polyclonal Antibody to Tissue Factor klhway Inhibitor (TFPI)
kl394Mu01 組織因子通道抑制因子(TFPI)多克隆抗體 Polyclonal Antibody to Tissue Factor klhway Inhibitor (TFPI)
kl394Ra01 組織因子通道抑制因子(TFPI)多克隆抗體 Polyclonal Antibody to Tissue Factor klhway Inhibitor (TFPI)
kl394Rb51 組織因子通道抑制因子(TFPI)多克隆抗體 Polyclonal Antibody to Tissue Factor klhway Inhibitor (TFPI)
kl395Hu01 抑制素A(INHA)多克隆抗體 Polyclonal Antibody to Inhibin A (INHA)
kl395Po01 抑制素A(INHA)多克隆抗體 Polyclonal Antibody to Inhibin A (INHA)
kl395Ra01 抑制素A(INHA)多克隆抗體 Polyclonal Antibody to Inhibin A (INHA)
kl396Hu01 性**結(jié)合球蛋白(SHBG)多克隆抗體 Polyclonal Antibody to Sex Hormone Binding Globulin (SHBG)
